Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Alanosine in Treating Patients With Cancer
This study is ongoing, but not recruiting participants.
Study NCT00062283 Information provided by National Cancer Institute (NCI)
First Received: June 5, 2003 Last Updated: July 23, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Lung Cancer
Malignant Mesothelioma
Pancreatic Cancer
Sarcoma
Additional conditions recognized in this trial
Lung Neoplasms
Mesothelioma
Pancreatic Neoplasms
More general conditions related to this trial
Adenoma
Digestive System Diseases
Digestive System Neoplasms
Endocrine Gland Neoplasms
Endocrine System Diseases
Lung Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Connective and Soft Tissue
Neoplasms, Glandular and Epithelial
Neoplasms, Mesothelial
Pancreatic Diseases
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Thoracic Neoplasms
Interventions listed in this trial
L-alanosine
Additional drug interventions recognized in this trial
Alanosine
More general drug interventions related to this trial
Antibiotics, Antineoplastic
Antineoplastic Agents
Chelating Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Memorial Sloan-Kettering Cancer Center
National Cancer Institute (NCI)
Back to top of Main Content
